28.05.2013 19:46:00

Bausch & Lomb B.V. -- Moody's puts Bausch & Lomb's ratings on review for upgrade

New York, May 28, 2013 -- Moody's Investors Service placed Bausch & Lomb Incorporated's ("Bausch's") debt ratings on review for upgrade following news that the company has signed a definitive agreement to be acquired by Valeant Pharmaceuticals International for $8.7 billion in cash. At the same time, Moody's affirmed Bausch's SGL-2 Speculative Grade Liquidity Rating. If all of Bausch's existing debt is retired, the ratings will be withdrawn. However any remaining debt could be upgraded.

Vollständigen Artikel bei Moodys lesen